Examining inpatient chemotherapy utilization among patients with cancer and impact on outcomes
IST was overutilized in ST patients with poor response rates and significant early mortality. PC service utilization rates remain low but improved end-of-life transition planning.
Authors
- Shivani Handa (ORCID: https://orcid.org/0000-0002-1932-6209)
- Cardinale B. Smith (ORCID: https://orcid.org/0000-0003-3635-8701)
- Giulia E.M. Petrone (ORCID: https://orcid.org/0000-0003-3166-4355)
- Deukwoo Kwon (ORCID: https://orcid.org/0000-0001-5376-5320)
- Priya Jain
- Aarti Sonia Bhardwaj (ORCID: https://orcid.org/0000-0001-5346-8131)
- Natalie Berger (ORCID: https://orcid.org/0000-0001-6922-6866)
- Justine Anderson
- Nobel Chowdhury
Institutions
- Northwell Health (US)
- Memorial Sloan Kettering Cancer Center (US)
- NewYork–Presbyterian Hospital (US)
- Hofstra University (US)
- Washington University in St. Louis (US)
- Columbia University Irving Medical Center (US)
- The Ohio State University Wexner Medical Center (US)
- Tisch Hospital (US)
- The University of Texas Health Science Center at Houston (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- The Oncologist
- Published
- 2025-10-28
- DOI
- https://doi.org/10.1093/oncolo/oyaf214
- Primary Topic
- Economic and Financial Impacts of Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00